Zydus receives FDA nod for Morphine Sulfate Tablets
02 July 2015 | News | By BioSpectrum Bureau
Zydus receives FDA nod for Morphine Sulfate Tablets
Morphine Sulfate Tablets is used in the treatment of pain
Zydus Group has received the final approval from the United States Food and Drug administration (USFDA) to market its Morphine Sulfate ER Tablets, used in the treatment of chronic pain or cancer related pain.
The Tablets will be manufactured by Nesher Pharmaceuticals, located at St.Louis, USA, the company said in afiling to the BSE.
Nesher Pharmaceuticals is a subsidary of Zydus Pharmaceuticals.
